In the Press

A new study analyzed genes in nasal swabs from asymptomatic people who tested positive for SARS-CoV-2.

WASHINGTON, Oct. 14, 2022 – The U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) today released a proposed regulatory framework for a new strategy to control Salmonella contamination in poultry products and reduce foodborne illnesses attributed to these products. The agency is hosting a virtual public meeting on Nov. 3, 2022, to seek input from stakeholders on the proposed framework.

Diabetes patients in low- and middle-income countries (LMICs) lack access to the insulin they need to manage their condition, with only 27% of 108 poor countries registering all the insulins classified as essential medicines by the World Health Organization (WHO)—and 22% registering none.

This 2-year, 28-day study examined whether adolescents felt greater fatigue and emotional distress the same day and the day after air quality was worse.

A German study published today in BMJ finds a considerable burden of long-COVID symptoms, especially fatigue and neurocognitive impairment ("brain fog"), at 6 to 12 months—even among young and middle-aged adults who had mild infections.

Adverse childhood experiences (ACEs) are associated with poor mental health and suicidal behaviors.

Monkeypox virus can be shed into the surrounding environment by people who are infected, particularly in shed skin particles and in debris from monkeypox skin lesions and scabs. The virus is relatively hardy and under appropriate conditions can remain infectious on surfaces for weeks, creating a potential infection risk to others.

The results of a phase 3 clinical trial indicate that a novel combination antibiotic may soon be available for treatment of complicated urinary tract infections (cUTIs) caused by multidrug-resistant gram-negative bacteria.

A new study that links the location of brain injury to levels of depression in patients following the injury has identified two distinct brain networks; one associated with increased depression symptoms and one associated with decreased depression symptoms. The large-scale study led by researchers with University of Iowa Health Care expands on previous findings and suggests that these brain networks might be potential targets for neuromodulation therapies to treat depression.